Imagion Biosystems Overview

  • Status
  • Public

  • Employees
  • 19

Employees

  • Stock Symbol
  • IBX

Stock Symbol

Imagion Biosystems General Information

Description

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer. The company operates in Australia and the USA, with revenue from Australia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 385 Bourke Street, Level 11
  • Suite 2
  • Melbourne, Victoria 3000
  • Australia
+61 (03)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Stock Exchange
ASX
Corporate Office
  • 385 Bourke Street, Level 11
  • Suite 2
  • Melbourne, Victoria 3000
  • Australia
+61 (03)

Imagion Biosystems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Imagion Biosystems Stock Performance

As of 19-Nov-2026, Imagion Biosystems’s current market cap is $2.71M with 803M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.71M 803M 2.45M

Imagion Biosystems Financials Summary

As of 30-Sep-2026, Imagion Biosystems has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 5,685 9,757 4,626 11,572
Revenue 765 908
EBITDA (2,246) (358) (6,791)
Net Income (2,777) (1,363) (8,279)
Total Assets 1,368 1,743 3,125
Total Debt 1,717 1,647 4,114
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Imagion Biosystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Imagion Biosystems‘s full profile, request access.

Request a free trial

Imagion Biosystems Patents

Imagion Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200187822-A1 Detection, measurement, and imaging of cells using cellular internalization of nanoparticles Inactive 15-Dec-2018
US-20170210773-A1 Synthesis of metal carboxylate compounds Inactive 02-Jun-2014
WO-2015187544-A1 Synthesis of metal carboxylate compounds Inactive 02-Jun-2014
US-20150293004-A1 Viscosity measuring method Inactive 01-Mar-2011
US-20130090545-A1 Methods and apparatuses for the localization and treatment of cancer Inactive 08-Jun-2010 A61B5/05
To view Imagion Biosystems’s complete patent history, request access »

Imagion Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imagion Biosystems ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Imagion Biosystems’s complete esg history, request access »

Imagion Biosystems FAQs

  • Where is Imagion Biosystems headquartered?

    Imagion Biosystems is headquartered in Melbourne, Australia.

  • What is the size of Imagion Biosystems?

    Imagion Biosystems has 19 total employees.

  • What industry is Imagion Biosystems in?

    Imagion Biosystems’s primary industry is Diagnostic Equipment.

  • Is Imagion Biosystems a private or public company?

    Imagion Biosystems is a Public company.

  • What is Imagion Biosystems’s stock symbol?

    The ticker symbol for Imagion Biosystems is IBX.

  • What is the current market cap of Imagion Biosystems?

    The current market capitalization of Imagion Biosystems is $2.71M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process